ConductScience.org, home

Paper36975019

Blood pressure control for diabetic retinopathy.

Do DV and 5 others. Cochrane Database Syst Rev, 2023. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Blood pressure control for diabetic retinopathy. Papers, record 36975019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36975019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blood pressure control for diabetic retinopathy.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2023
PubMed
Publication types
Systematic Review, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
7.57
iCite
Revised in PubMed
2025-10-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Do DVDiana V
2Han GGenie
3Abariga SASamuel A
4Sleilati GGina
5Vedula SSS Swaroop
6Hawkins BSBarbara S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic RetinopathyMajor topic
Macular EdemaMajor topic
Diabetes Mellitus, Type 2Major topic
HypertensionMajor topic
Humans
Blood Pressure
Antihypertensive Agents
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 EY020522NEI NIH HHSUnited StatesU01EY020522PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00134160OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyDerived from the trialYesClinicalTrials.gov
NCT00185159Olmesartan Medoxomil in Diabetes MellitusDerived from the trialYesClinicalTrials.gov
NCT00237549The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care.Derived from the trialYesClinicalTrials.gov
NCT00320008Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and MicroalbuminuriaDerived from the trialYesClinicalTrials.gov
NCT00542178Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)Derived from the trialYesClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Update of25637717Blood pressure control for diabetic retinopathy.https://conductscience.org/library/papers/25637717PubMed
Comment in39172669Blood Pressure Control for Patients With Diabetic Retinopathy.https://conductscience.org/library/papers/39172669PubMed

Download CSV of comments and corrections

References188

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18960842Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.Diabetologia1996https://conductscience.org/library/papers/8960842PubMed
218443195Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study.Diabetes Care2008https://conductscience.org/library/papers/18443195PubMed
317712074Management of diabetic retinopathy: a systematic review.JAMA2007https://conductscience.org/library/papers/17712074PubMed
48366922The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med1993https://conductscience.org/library/papers/8366922PubMed
59702425Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.Diabetes Care1998https://conductscience.org/library/papers/9702425PubMed
631748169Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.Lancet Diabetes Endocrinol2019https://conductscience.org/library/papers/31748169PubMed
72866759Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.Arch Ophthalmol1985https://conductscience.org/library/papers/2866759PubMed
815111519Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care2004https://conductscience.org/library/papers/15111519PubMed
92684072Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?Arch Intern Med1989https://conductscience.org/library/papers/2684072PubMed
107732997Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.Am J Cardiol1995https://conductscience.org/library/papers/7732997PubMed
1117199216Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy.J Renin Angiotensin Aldosterone Syst2000https://conductscience.org/library/papers/17199216PubMed
1221309844Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.Diabet Med2011https://conductscience.org/library/papers/21309844PubMed
131778353UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.Diabetologia1991https://conductscience.org/library/papers/1778353PubMed
142062513
Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology1991https://conductscience.org/library/papers/2062513PubMed
159052629Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.Ophthalmology1997https://conductscience.org/library/papers/9052629PubMed
1618823656Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.Lancet2008https://conductscience.org/library/papers/18823656PubMed
179538987Diabetic retinopathy. American Diabetes Association.Diabetes Care1998https://conductscience.org/library/papers/9538987PubMed
1822435949Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus.Geriatr Gerontol Int2012https://conductscience.org/library/papers/22435949PubMed
1911849464Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.Kidney Int2002https://conductscience.org/library/papers/11849464PubMed
2015078673The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States.Arch Ophthalmol2004https://conductscience.org/library/papers/15078673PubMed

See all 188 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42840144Factors associated with diabetic retinopathy: a cross-sectional study of 1477 patients across four cities in Anhui, China.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42840144PubMed
42728351Incidence and baseline predictors of discontinuation in DRCRnet studies.Eye (Lond)2026https://conductscience.org/library/papers/42728351PubMed
42665824Predictors of time to diabetic retinopathy in patients with type 2 diabetes mellitus: a survival analysis study.BMC Ophthalmol2026https://conductscience.org/library/papers/42665824PubMed
42429883Association of rate-pressure product with diabetic retinopathy in patients with type 2 diabetes mellitus: development and internal validation of a nomogram for diabetic retinopathy identification.Endocrine2026https://conductscience.org/library/papers/42429883PubMed
42356165Foveal Density and Multi-Domain OCTA Biomarkers May Help Identify Preclinical Diabetic Microvasculopathy in Type 2 Diabetes Mellitus.Medicina (Kaunas)2026https://conductscience.org/library/papers/42356165PubMed
42344825Diabetic Retinopathy in Bahraini Primary Care: A Cross-Sectional Study of Prevalence and Clinical Predictors.Cureus2026https://conductscience.org/library/papers/42344825PubMed
42227809Retinal Ischemic Perivascular Lesions Screen for Vision-Threatening Diabetic Retinopathy Visualized on Ultra-Widefield Fluorescein Angiography.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42227809PubMed
42174000Identification and analysis of oxidative stress-related genes associated with the occurrence and development of diabetic retinopathy.Sci Rep2026https://conductscience.org/library/papers/42174000PubMed
42005910Retinal Ischemic Perivascular Lesions are Associated with Multifactorial Disease Burden and Severity of Diabetic Retinopathy.Ophthalmol Sci2026https://conductscience.org/library/papers/42005910PubMed
41821747A clinically actionable nomogram integrating HbA1c, renal function, and blood pressure for early prediction of diabetic macular edema in working-age patients with type 2 diabetes.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41821747PubMed
41726296Impact of Fasting Plasma Glucose on Electrolyte Imbalance, Lipid Profile, and Associated Health Complications in Type 1 and Type 2 Diabetic Patients: A Cross-Sectional Study in Rural Bangladesh.Health Sci Rep2026https://conductscience.org/library/papers/41726296PubMed
41606655Targeting endoplasmic reticulum stress in diabetic retinopathy: mechanistic insights and emerging therapies.Biol Res2026https://conductscience.org/library/papers/41606655PubMed
41571723Clinical implications of systolic blood pressure for diabetic retinopathy across HbA1c levels in a Japanese population.Sci Rep2026https://conductscience.org/library/papers/41571723PubMed
41555800Nationwide Trends and Future Projections of Diabetes and Diabetic Retinopathy Prevalence in Korea: Korean National Health and Nutrition Examination Survey Study.J Korean Med Sci2026https://conductscience.org/library/papers/41555800PubMed
41414742Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial.J Diabetes2025https://conductscience.org/library/papers/41414742PubMed
41362404The Relationship Between Hemoglobin Levels and Proliferative Diabetic Retinopathy in Type 2 Diabetes Patients.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/41362404PubMed
41153024Blood pressure variability is associated with the occurrence of diabetic microangiopathy in type 2 diabetes mellitus: a cross-sectional study.Eur J Med Res2025https://conductscience.org/library/papers/41153024PubMed
41019873Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy.Clin Ophthalmol2025https://conductscience.org/library/papers/41019873PubMed
40935427Exploring potential target drugs for vision-threatening diabetic retinopathy using the human plasma proteome: a Mendelian randomisation study.BMJ Open2025https://conductscience.org/library/papers/40935427PubMed
40772141Metformin in Diabetic Retinopathy: Mechanisms, Therapeutic Potential, and Barriers.Cureus2025https://conductscience.org/library/papers/40772141PubMed

See all 33 cited byDownload CSV of cited by

Drugs5

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
SIMVASTATINCHEMBL1064Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1064ChEMBL
OLMESARTAN MEDOXOMILCHEMBL1200692Derived from the trial2https://conductscience.org/library/drugs/CHEMBL1200692ChEMBL
AZELNIDIPINECHEMBL1275868Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1275868ChEMBL
AMLODIPINECHEMBL1491Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1491ChEMBL
FENOFIBRATECHEMBL672Derived from the trial1https://conductscience.org/library/drugs/CHEMBL672ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36975019

GET https://conductscience.org/api/papers/v1/36975019/references?page=2